Cardiff Oncology Ownership | Who Owns Cardiff Oncology?
Cardiff Oncology Ownership Summary
Cardiff Oncology is owned by 27.54% institutional investors, 5.91% insiders, and 66.55% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 5.96% of CRDF shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.03% of its assets in Cardiff Oncology shares.
CRDF Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cardiff Oncology | 27.54% | 5.91% | 66.55% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 3.98M | 5.96% | $6.45M |
| Blackrock | 2.63M | 5.88% | $5.84M |
| Vanguard group | 3.72M | 5.57% | $10.46M |
| Laurion capital management lp | 2.65M | 3.96% | $4.29M |
| Pfizer | 2.41M | 3.61% | $3.74M |
| Acorn capital advisors | 1.76M | 2.64% | $2.85M |
| Geode capital management | 1.60M | 2.39% | $2.59M |
| Franklin resources | 1.21M | 1.80% | $1.95M |
| State street | 1.19M | 1.78% | $1.92M |
| Blair william & co/il | 922.41K | 1.38% | $1.49M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pfizer | 2.41M | 1.57% | $3.74M |
| Acorn capital advisors | 1.76M | 0.81% | $2.85M |
| Laurion capital management lp | 2.65M | 0.19% | $4.29M |
| Elkhorn partners limited partnership | 44.50K | 0.05% | $72.09K |
| Callan capital | 101.58K | 0.03% | $440.84K |
| Findec wealth services | 16.00K | 0.03% | $25.92K |
| Post resch tallon group | 22.52K | 0.03% | $38.50K |
| Flputnam investment management | 595.13K | 0.01% | $964.11K |
| Avestar capital | 136.15K | 0.01% | $220.56K |
| Gsa capital partners llp | 123.01K | 0.01% | $199.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.63M | 0.00% | 1.95M |
| Vanguard fiduciary trust | 446.23K | 0.00% | 446.23K |
| Ubs group | 400.58K | 0.00% | 313.15K |
| Nuveen asset management | 586.62K | 0.00% | 248.85K |
| National bank of canada /fi/ | 208.70K | 0.00% | 208.67K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | - | - | -5.38M |
| Adage capital partners gp | - | - | -1.42M |
| Blair william & co/il | 922.41K | 0.00% | -1.03M |
| Orbimed advisors | - | - | -573.88K |
| Two sigma investments, lp | 206.99K | 0.00% | -517.97K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 446.23K | 0.00% | 446.23K | $722.88K |
| Cubist systematic strategies | 88.90K | 0.00% | 88.90K | $183.14K |
| Sei investments | 54.69K | 0.00% | 54.69K | $88.59K |
| Squarepoint ops | 26.36K | 0.00% | 26.36K | $42.70K |
| Vanguard global advisers | 25.27K | - | 25.27K | $40.94K |
Sold Out
| Holder | Change |
|---|---|
| Cornerstone planning group | -5.00 |
| True wealth design | -14.00 |
| Newbridge financial services group | -17.00 |
| Larson financial group | -328.00 |
| Eagle bay advisors | -339.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 82 | -27.43% | 18,404,736 | -32.46% | 27 | 1.66% | 35 | -18.60% | 24 | -25.00% |
| Dec 31, 2025 | 89 | -27.05% | 23,875,920 | -5.33% | 35 | 2.48% | 33 | -40.00% | 27 | -3.57% |
| Sep 30, 2025 | 118 | 1.72% | 25,164,533 | -9.21% | 37 | 2.18% | 52 | -14.75% | 28 | 40.00% |
| Jun 30, 2025 | 118 | -4.84% | 28,608,900 | -11.55% | 43 | 1.82% | 63 | -5.97% | 22 | 15.79% |
| Mar 31, 2025 | 7 | -94.44% | 1,488,712 | -94.70% | 2 | 0.06% | 4 | -94.87% | 1 | -93.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.07M | 3.03% | - |
| iShares Russell 2000 ETF | 1.48M | 2.16% | 12.46K |
| Vanguard US Total Market Shares ETF | 1.25M | 1.89% | - |
| CREF Stock R1 | 1.25M | 1.87% | 17.50K |
| Franklin Biotechnology Discv A(acc)USD | 766.68K | 1.12% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 762.04K | 1.11% | 44.38K |
| Fidelity Small Cap Index | 605.94K | 0.89% | 4.66K |
| CREF Stock R3 | 443.15K | 0.67% | -36.90K |
| Franklin Biotechnology Discovery A | 438.96K | 0.64% | - |
| Fidelity Extended Market Index | 383.38K | 0.56% | 26.24K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 30, 2025 | PACE GARY W | - | Buy | $673.75K |
| Jul 30, 2025 | PACE GARY W | - | Buy | $36.75K |
| Dec 17, 2024 | Levine James E. | Chief Financial Officer | Buy | $14.91K |
| Dec 18, 2024 | Levine James E. | Chief Financial Officer | Buy | $12.00K |
| Dec 16, 2024 | Levine James E. | Chief Financial Officer | Buy | $9.82K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q3 | 2 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
CRDF Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools